Profilo
Jacob J.
Clement joined MIGENIX, Inc. in August 2002.
He is Chief Science Officer and Senior Vice President-Science and Technology for MIGENIX.
Previously, he held various executive and senior management positions with Abbott Laboratories, Scriptgen Pharmaceuticals and Essential Therapeutics.
Dr. Clement received a PhD and a MSPH from the University of North Carolina, an MS degree from Roosevelt University and a BA degree from St. Mary's University.
Precedenti posizioni note di Jacob J. Clement
| Società | Posizione | Fine |
|---|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Direttore Tecnico/Scientifico/R&S | 31/01/2009 |
Formazione di Jacob J. Clement
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Roosevelt University
Roosevelt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Mary's University
Saint Mary's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















